SIRT7 and prostate carcinoma: Hypoacetylation of H3AcK18 is associated to prostate carcinoma with poor prognosis [58], and increase of H3AcK18 caused by absence of SIRT7 at sites of DNA damage affects the maintenance of genome integrity [59].